ABSTRACT
BACKGROUND: Ganoderma lucidum has certain components with known pharmacological effects, including strengthening immunity and anti-inflammatory activity. G. lucidum seeds inherit all its biological characteristics. G. lucidum spore polysaccharide (GLSP) is the main active ingredient to enhance these effects. However, its specific biological mechanisms are not exact. Our research is aimed at revealing the specific biological mechanism of GLSP to enhance immunity and inhibit the growth of H22 hepatocellular carcinoma cells. METHODS: We extracted primary macrophages (Mø) from BALB/c mice and treated them with GLSP (800 µg/mL, 400 µg/mL, and 200 µg/mL) to observe its effects on macrophage polarization and cytokine secretion. We used GLSP and GLSP-intervened macrophage supernatant to treat H22 tumor cells and observed their effects using MTT and flow cytometry. Moreover, real-time fluorescent quantitative PCR and western blotting were used to observe the effect of GLSP-intervened macrophage supernatant on the PI3K/AKT and mitochondrial apoptosis pathways. RESULTS: In this study, GLSP promoted the polarization of primary macrophages to M1 type and the upregulation of some cytokines such as TNF-α, IL-1ß, IL-6, and TGF-ß1. The MTT assay revealed that GLSP+Mø at 400 µg/mL and 800 µg/mL significantly inhibited H22 cell proliferation in a dose-dependent manner. Flow cytometry analysis revealed that GLSP+Mø induced apoptosis and cell cycle arrest at the G2/M phase, associated with the expression of critical genes and proteins (PI3K, p-AKT, BCL-2, BAX, and caspase-9) that regulate the PI3K/AKT pathway and apoptosis. GLSP reshapes the tumor microenvironment by activating macrophages, promotes the polarization of primary macrophages to M1 type, and promotes the secretion of various inflammatory factors and cytokines. CONCLUSION: Therefore, as a natural nutrient, GLSP is a potential agent in hepatocellular carcinoma cell treatment and induction of apoptosis.
Subject(s)
Carcinoma, Hepatocellular/therapy , Fungal Polysaccharides/metabolism , Liver Neoplasms/therapy , Macrophages/immunology , Reishi/immunology , Animals , Apoptosis , Cell Differentiation , Cells, Cultured , Cytokines/metabolism , Macrophage Activation , Mice , Mice, Inbred BALB C , Phosphatidylinositol 3-Kinases/metabolism , Phytotherapy/trends , Signal Transduction , Spores, Fungal , Th1 Cells/immunologyABSTRACT
Background:Ganoderma lucidum has been used in Chinese medicine for thousands years to improve health and to promote longevity. One important function of G lucidum is to modulate the immune system. However, the underlying mechanism is not well understood. Programmed cell death protein 1 (PD-1) is a cell surface protein present in certain immune cells (eg, B- and Tcells) and plays an important role in modulating the immune response. The role of PD-1 protein in G lucidum-mediated immunomodulation is unknown. Methods: Cultured human Blymphocytes and extract prepared from G lucidum spores (GLE) were used to determine PD-1 protein in G lucidum-mediated immunomodulation. Both western blotting and immunofluorescence (IF) microscopy assays were used to determine the effect of GLE treatment on PD-1 protein expression. A reverse transcription-based quantitative polymerase chain reaction (real-time PCR) assay was used to determine the effect of GLE on transcription of pdcd-1 gene. Results: Both our western blotting and IF staining results demonstrated great reduction in PD-1 protein and in proportion of PD-1+ cells in these B-lymphocytes. Our real-time PCR results indicated that this PD-1 protein reduction was not caused by a transcriptional inhibition of the gene. In addition, our western blotting study further revealed that the GLE treatment caused an increase in expression of CCL5 chemokine in the cultured B-lymphocytes. Conclusions: PD-1 protein is an important target of G lucidum-mediated immunomodulation. G lucidum and its bioactive compounds can be developed into novel immunomodulators for prevention and treatment of cancer and many other diseases.
Subject(s)
Immunomodulation/immunology , Neoplasms/immunology , Neoplasms/therapy , Programmed Cell Death 1 Receptor/immunology , Reishi/immunology , Biological Products/immunology , Cell Line, Tumor , Chemokine CCL5/immunology , Humans , Medicine, Chinese Traditional/methods , Transduction, Genetic/instrumentationABSTRACT
Ganoderma lucidum (Fr.) Karst (Ganodermataceae) is a medicinal mushroom that has been extensively used in China for centuries to promote longevity and improve vigor without significant adverse effects. There is continuous interest in the bioactive properties of G. lucidum in view of its newly developed popularity in other regions besides Asia, such as Europe. Glycopeptide derived from G. lucidum (Gl-PS) is one of the main effective components isolated from this mushroom. The Gl-PS has been demonstrated pleiotropic with many bioactivities including immunomodulatory and antitumor effects. Macrophages are important cells involved in innate and adaptive immunity. Classically activated macrophages (M1) and alternatively activated macrophages (M2), with their different roles, display distinct cytokine profiles: M1 preferentially produces TNF-α, IL-6, and IL-12; conversely, M2 generates more IL-10 and arginase. Gl-PS might have the potential to promote macrophage M1 polarization by lipopolysaccharide (LPS). In this study, LPS was used to induce the M1 polarization. It was shown that the level of the TNF-α, IL-6, and IL-12 were increased and the IL-10 and arginase I were decreased in the polarized M1 macrophages after application of Gl-PS compared to the control. The results indicated the potential of Gl-PS to promote M1 polarization vs M2, with the health beneficial understanding of the bioactivities of Gl-PS.
Subject(s)
Antigens, Plant/pharmacology , Glycopeptides/pharmacology , Macrophages, Peritoneal/immunology , Animals , Arginase/metabolism , Cell Differentiation/drug effects , Cells, Cultured , Cytokines/metabolism , Inflammation Mediators/metabolism , Macrophage Activation/drug effects , Macrophages, Peritoneal/parasitology , Medicine, Chinese Traditional , Mice , Mice, Inbred C57BL , Reishi/immunologyABSTRACT
The aim of this study was to investigate the anti-inflammatory and hepatoprotective effects of Ganoderma lucidum polysaccharides (GLPS) on carbon tetrachloride (CCl4)-induced hepatocyte damage in common carp (Cyprinus carpio L.). GLPS (0.1, 0.3, 0.6mg/ml) were added to the primary hepatocytes before (pre-treatment), after (post-treatment) and both before and after (pre- and post-treatment) the incubation of the hepatocytes with CCl4 at the concentration of 8mM in the culture medium. The supernatants and cells were collected respectively to detect the biochemical indicators. The levels of TNF-α, IL-1ß, caspase-3 and caspase-8 were measured by ELISA, the mRNA expressions of CYP1A and CYP3A were determined by RT-PCR, and western blotting was used to assay the relative protein expressions of c-Rel and p65. Results showed that GLPS significantly improved cell viability and inhibited the elevations of the marker enzymes (GOT, GPT, LDH) and MDA induced by CCl4, and markedly increased the level of SOD. Treatments with GLPS resulted in a significant decrease in the expressions of CYP1A and CYP3A, and significantly down-regulated extrinsic apoptosis and immune inflammatory response. In brief, the present study showed that GLPS can protect hepatocyte injury induced by CCl4 through inhibiting lipid peroxidation, elevating antioxidant enzyme activity and suppressing apoptosis and immune inflammatory response.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Fungal Polysaccharides/pharmacology , Hepatocytes/drug effects , Medicine, Chinese Traditional , Reishi/immunology , Animals , Apoptosis/drug effects , Carbon Tetrachloride/toxicity , Carps , Caspase 3/metabolism , Caspase 8/metabolism , Cell Survival/drug effects , Cells, Cultured , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/metabolism , Cytochrome P-450 CYP3A/genetics , Cytochrome P-450 CYP3A/metabolism , Hepatocytes/pathology , Hepatocytes/physiology , Interleukin-1beta/metabolism , Lipid Peroxidation/drug effects , Tumor Necrosis Factor-alpha/metabolismABSTRACT
The indoleamine 2,3-dioxygenase-(IDO-) mediated microenvironment plays an important role in tumor immune escape. It is known that ganoderic acid Me can enhance IFN-γ expression and IDO is preferentially induced by IFN-γ. However, whether GA-Me can induce IDO expression has not been clarified yet. We established stable clones of IDO-overexpressing 2 LL cells (2LL-EGFP-IDO). After co-culturing with IDO expressing or control vector-transfected 2LL-EGFP cells, T cell apoptosis was determined and the proportion of the regulatory T cells (Tregs) and CD8+ T cell subset was measured. The total cellular protein samples of 2 LL-EGFP-IDO cells were isolated for detecting JAK-STAT1 signalling pathway. Co-culture supernatants were used to detect amino acids and cytokines. IDO transfected 2 LL cells yielded high level of IDO enzymatic activity, resulting in complete depletion of tryptophan from the culture medium. We found that apoptosis occurred in T cells after cocultured with IDO+2LL cells and the proportion of CD4+CD25+ cells and FoxP3+ cells increased while CD8+ cells decreased. The specific inhibitor of IDO, 1-D-MT and GA-Me efficiently enhanced T cell apoptosis, increased Tregs, and reduced CD8+ T cells in vitro. Increased expression of IDO, p-JAK1 and p-STAT1 were confirmed by Western blot analysis. The levels of IFN-γ, IL-10, LDH and kynurenine in co-culture supernatant correspondingly increased, while tryptophan reduced. These results suggest that GA-Me contributing to IDO helps to create a tolerogenic milieu in lung tumors by directly inducing T cell apoptosis, restraining CD8+ T cell activation, and enhancing Treg-mediated immunosuppression.
Subject(s)
CD8-Positive T-Lymphocytes/drug effects , Carcinoma, Lewis Lung/drug therapy , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Phytotherapy/methods , T-Lymphocytes, Regulatory/drug effects , Triterpenes/pharmacology , Animals , Apoptosis/drug effects , CD8-Positive T-Lymphocytes/immunology , Carcinoma, Lewis Lung/immunology , Clone Cells , Coculture Techniques , Humans , Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics , Interferon-gamma/metabolism , Interleukin-1/metabolism , Janus Kinases/metabolism , Mice , Mice, Inbred C57BL , Reishi/immunology , STAT1 Transcription Factor/metabolism , Signal Transduction/drug effects , T-Lymphocytes, Regulatory/immunology , Tumor EscapeABSTRACT
Acute inflammation is the result of a complex signal transduction pathway that protects and heals our body and is necessary for our good health and normal wellbeing. Whereas, chronic inflammation can be correlated well with the onset of a plethora of autoimmune disorders; rheumatoid arthritis, systemic lupus and polymyalgia, rheumatic and other diseases like asthma, inflammatory bowel diseases, cardiovascular disorders, ulcerative colitis and Crohn's disease. Also, it has been reported to be associated with the onset of various cancers. An effective anti-inflammatory drug should be able to inhibit the development of chronic inflammation without interfering in normal homeostasis. A number of herbal drugs have been identified in the past that can target inflammatory cytokines. Among these, Ganoderma lucidum: a powerful medicinal mushroom has been found to possess immune-modulating and immune-potentiating capabilities and has been characterized as a wonder herb. This review mainly focuses on the molecular mechanism of anti-inflammatory and antiallergic action of this mushroom and also sheds light on various patent studies related to its pharmacological action.
Subject(s)
Anti-Allergic Agents/pharmacology , Anti-Inflammatory Agents/pharmacology , Autoimmune Diseases/therapy , Drugs, Chinese Herbal/pharmacology , Hypersensitivity/therapy , Reishi/immunology , Animals , Autoimmune Diseases/immunology , Humans , Hypersensitivity/immunology , Immunomodulation , Patents as TopicABSTRACT
Nervous necrosis virus (NNV) infection during larvae and juvenile stage in grouper (Epinephelus coioides) has caused severe economic losses in the aquaculture industry in Asia. The aims of this study were to evaluate the influence of recombinant Reishi protein, rLZ-8, on the innate immune responses and the viral resisting ability in fish. Groupers were fed with rLZ-8 supplemented diet (1.25-37.5 mg (rLZ-8)/kg(diet)), and the cytokine gene expression, innate immune responses, and survival rate after NNV challenge were examined. The fish fed with rLZ-8 diet showed 6- to 11-fold upregulated TNF-α and IL-1ß gene expression, along with significant increased respiratory burst and phagocytic activity. Moreover, feeding the fish with 37.5 mg/kg rLZ-8 diet elicited significant improvement in post viral challenge survival rate (85.7%). These discoveries indicated that rLZ-8 could be utilized as an ant-pathogen immunostimulant, and provided a new candidate to fight against NNV infection in fish.
Subject(s)
Diet/veterinary , Fish Diseases/immunology , Immunity, Innate/drug effects , Immunologic Factors/pharmacology , RNA Virus Infections/veterinary , Reishi/immunology , Animals , Cells, Cultured , Cytokines/genetics , Dietary Supplements , Fungal Proteins , Gene Expression Regulation/drug effects , Leukocytes/drug effects , Nodaviridae , Phagocytosis/drug effects , RNA Virus Infections/immunology , Recombinant Proteins/pharmacology , Reishi/chemistry , Respiratory Burst/drug effectsABSTRACT
Ganoderma lucidum Karst is well known as 'Reishi', a traditional food in China and Japan. It contains a polysaccharide component known to induce granulocyte macrophage colony-stimulating factor (GM-CSF) production from murine splenocytes. Moreover, GM-CSF may be a therapeutic agent for Crohn's disease. In this study, we investigated the water-soluble, polysaccharide components of Reishi (designated as MAK) in murine colitis induced by trinitrobenzene sulphonic acid (TNBS). We examined the concentration of GM-CSF in peritoneal macrophage cells (PMs) of C57BL/6 mice during in vitro and in vivo stimulation with MAK. After feeding with chow or MAK for 2 weeks, 2 mg of TNBS/50% ethanol was administered to each mouse. After 3 days of TNBS treatment, intestinal inflammation was evaluated, and mononuclear cells of the mesenteric lymph nodes (MLNs) and colon were cultured for ELISA. To determine the preventive role of GM-CSF, the mice were pre-treated with or without anti-GM-CSF antibody before TNBS administration. In vitro and in vivo MAK-stimulated PMs produced GM-CSF in a dose-dependent manner. Intestinal inflammation by TNBS was improved by feeding with MAK. MLNs of mice treated with TNBS produced IFN-γ, which was inhibited by feeding with MAK. In contrast, MLNs of mice treated with TNBS inhibited GM-CSF production, which was induced by feeding with MAK. The colon organ culture assay also revealed that IFN-γ was decreased and GM-CSF was increased by MAK. The preventive effect was blocked by the neutralization of GM-CSF. We concluded that the induction of GM-CSF by MAK may provide the anti-inflammatory effect.
Subject(s)
Colitis/drug therapy , Colon/drug effects , Macrophages, Peritoneal/drug effects , Mycelium/metabolism , Reishi/immunology , Animals , Anti-Inflammatory Agents/administration & dosage , Antibodies, Monoclonal/administration & dosage , Cells, Cultured , Colitis/chemically induced , Colitis/pathology , Colitis/physiopathology , Colon/immunology , Colon/pathology , Culture Media/metabolism , Disease Models, Animal , Drugs, Chinese Herbal/administration & dosage , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Humans , Interferon-gamma/genetics , Interferon-gamma/metabolism , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/pathology , Mice , Mice, Inbred C57BL , Mycelium/growth & development , Trinitrobenzenesulfonic Acid/administration & dosageABSTRACT
Ganoderma lucidum (G. lucidum) is a medicinal mushroom having biological effects such as immunomodulation and anti-tumor actions. In China and many other Asian countries, G. lucidum is used as a folk remedy to promote health and longevity. Although many studies have shown that G. lucidum modulates the immune system, including, for example, antigen-presenting cells, natural killer (NK) cells, and the T and B lymphocytes, the effects of G. lucidum on the WEHI-3 leukemic BALB/c mice are unclear. We attempted to determine whether G. lucidum would promote immune responses in BALB/c mice injected with WEHI-3 leukemia cells. The effects of G. lucidum on the survival rate of WEHI-3 leukemia cells injected into BALB/c mice were examined. It increased the percentages of CD3 and CD19, but decreased the percentages of Mac-3 and CD11b markers, suggesting that differentiation of the precursor of T and B cells was promoted but macrophages were inhibited. It decreased the weight of spleens as compared with control mice. It also promoted phagocytosis by macrophage from peripheral blood mononuclear cell (PBMC) and it also promoted natural killer cell activity. It decreased the percentage of leukemia cells in the spleens of mice before they were injected with WEHI-3 cells. Apparently, G. lucidum affects murine leukemia WEHI-3 cells in vivo.
Subject(s)
Leukemia/immunology , Leukemia/pathology , Reishi/chemistry , Reishi/immunology , Animals , Biomarkers/metabolism , Cell Extracts/immunology , Cell Extracts/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Concanavalin A/immunology , Injections , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Leukocytes/drug effects , Leukocytes/immunology , Leukocytes/metabolism , Liver/drug effects , Liver/pathology , Macrophages/drug effects , Macrophages/immunology , Male , Mice , Mice, Inbred BALB C , Phagocytosis/drug effects , Phagocytosis/immunology , Spleen/drug effects , Spleen/immunology , Spleen/pathology , Survival Analysis , Time Factors , Xenograft Model Antitumor AssaysABSTRACT
The effect of Chinese herbs (Astragalus radix and Ganoderma lucidum) on immune response of carp was investigated. Fish were fed diets containing Astragalus (0.5%), Ganoderma (0.5%) and combination of two herbs (Astragalus 0.5% and Ganoderma 0.5%) for 5 weeks. Other groups of fish were vaccinated (i.p.) against Aeromonas hydrophila/Aeromonas salmonicida (Shering Plough, Essex, U.K.) at the beginning of the experiment and fed the same diets as described above. Control fish (negative control) and fish vaccinated only (positive control) were fed basal diets without supplements of herbs. The respiratory burst activity, phagocytosis, lysozyme activity and circulatory antibody titres in plasma were monitored. Following 5 weeks after feeding, fish were infected with A. hydrophila and mortalities were recorded. The results of this study showed that feeding non-vaccinated and vaccinated carp with combination of Astragalus and Ganoderma stimulated respiratory burst activity, phagocytosis of phagocytic cells in blood and lysozyme and circulatory antibody titres in plasma in vaccinated carp. Fish challenged with A. hydrophila had variable survival. The best survival (60%) was in vaccinated group fed with both herbs, while almost 90% of control fish (negative control) and 60% of fish vaccinated only (positive control) died.
Subject(s)
Astragalus Plant/immunology , Carps/immunology , Drugs, Chinese Herbal/pharmacology , Fish Diseases/immunology , Gram-Negative Bacterial Infections/immunology , Immunity, Mucosal/drug effects , Reishi/immunology , Adjuvants, Immunologic/pharmacology , Aeromonas hydrophila/immunology , Animals , Fish Diseases/mortality , Fish Diseases/prevention & control , Gram-Negative Bacterial Infections/mortality , Gram-Negative Bacterial Infections/prevention & control , Phagocytosis/drug effects , Respiratory Burst/drug effectsABSTRACT
Nasal immunotherapy with allergen has been reported to be effective for airway allergic disease. A group of 50 male Balb/c mice were immunized intraperitoneally with recombinant Dermatophagoides pteronyssinus group 2 (rDp2), then oral feeding with Ganoderma lucidum (known as "Ling Zhi," LZ OT) and intranasal therapy with native Dp2 (Dp2 NT) were given, the mice then received intratracheal challenge with rDp2 at 28 days and 35 days after immunization. Airway hypersensitivity to methacholine was measured 30 min (early phase) and 24 h (late phase) after the second challenge. The cytokine producing CD4 cells in PBL and interferon-gamma (IFN-gamma) concentrations in bronchoalveolar lavage fluid and sera were measured on 37 days after immunization. Both Dp2 NT and LZ OT downregulated total inflammatory cell infiltration in the airway. Dp2 NT reduced IL-5+/CD4+ cells and increased IFN-gamma+/CD4+ cells. When LZ OT was added to Dp2 NT, the reduction of IL-5+/CD4+ cells was diminished and the increment of IFN-gamma+/CD4+ cells was increased. LZ OT alone increased both IL-5+/CD4+ cells and IFN-gamma+/CD4+ cells. When LZ OT was added to Dp2 NT, IgG2a was further increased to a significant level. LZ OT alone significantly suppressed IgG1 and increased IgG2a production. When lung function was measured after therapy, early phase airway hypersensitivity to methacholine significantly suppressed by Dp2 NT, while late phase hypersensitivity was suppressed but not to a significant level. When LZ OT was added to Dp2 NT, the suppression of late phase airway hypersensitivity to methacholine reached a significant level. In this mouse model of Dp2-induced airway hypersensitivity, Dp2 NT downregulated airway inflammatory cell infiltration and decreased immediate airway hypersensitivity to methacholine. When LZ OT was coadministered, the airway lymphocytes and circulatory IFN-gamma+/CD4+ were both increased and late phase airway hypersensitivity was decreased. These results suggest that Dp2 NT might have a therapeutic effect on Dp2-induced airway hypersensitivity and LZ OT might also have an effect on Dp2 NT immunotherapy.
Subject(s)
Adjuvants, Immunologic/therapeutic use , Antigens, Dermatophagoides/therapeutic use , Asthma/therapy , Reishi/immunology , Adjuvants, Immunologic/administration & dosage , Administration, Intranasal , Administration, Oral , Animals , Antigens, Dermatophagoides/administration & dosage , Arthropod Proteins , Asthma/chemically induced , Asthma/immunology , CD4-Positive T-Lymphocytes/immunology , Dermatophagoides pteronyssinus , Disease Models, Animal , Drug Therapy, Combination , Immunoglobulin G/blood , Inflammation/chemically induced , Inflammation/immunology , Interferon-gamma/blood , Lymphocyte Count , Male , Mice , Mice, Inbred BALB C , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Recombinant ProteinsABSTRACT
From a lipophilic extract of the fruiting body of Ganoderma lucidum, three new lanostanoids, 8beta,9alpha-dihydroganoderic acid J (1), methyl 8beta,9alpha-dihydroganoderate J (2), and 20-hydroxylganoderic acid G (3), along with 12 known lanostanoids and two ergostane sterols were isolated. The structures of 1-3 were determined by interpretation of their spectroscopic data.